0RV1 Stock Overview Provides occupational healthcare services in Finland and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Terveystalo Oyj Competitors Price History & Performance
Summary of share price highs, lows and changes for Terveystalo Oyj Historical stock prices Current Share Price €10.42 52 Week High €11.00 52 Week Low €7.05 Beta 0.64 1 Month Change 5.04% 3 Month Change 10.38% 1 Year Change 31.24% 3 Year Change -10.48% 5 Year Change -5.96% Change since IPO 0.97%
Recent News & Updates
New minor risk - Financial position Oct 27
Third quarter 2024 earnings released: EPS: €0.12 (vs €0.026 in 3Q 2023) Oct 25 Terveystalo Oyj, Annual General Meeting, Apr 08, 2025
Upcoming dividend of €0.15 per share Oct 01
Terveystalo Oyj Elects Risto Murto as Chairman of Shareholders' Nomination Board Sep 27
Terveystalo Oyj Announces Resignation of Petri Bono as Chief Medical Officer and Member of the Executive Team, Effective 14 August 2024 Aug 06 See more updates
New minor risk - Financial position Oct 27
Third quarter 2024 earnings released: EPS: €0.12 (vs €0.026 in 3Q 2023) Oct 25 Terveystalo Oyj, Annual General Meeting, Apr 08, 2025
Upcoming dividend of €0.15 per share Oct 01
Terveystalo Oyj Elects Risto Murto as Chairman of Shareholders' Nomination Board Sep 27
Terveystalo Oyj Announces Resignation of Petri Bono as Chief Medical Officer and Member of the Executive Team, Effective 14 August 2024 Aug 06
Second quarter 2024 earnings released: EPS: €0.11 (vs €0.059 in 2Q 2023) Jul 18
Terveystalo Oyj Updates Earnings Guidance for the Year 2024 Jul 11
Terveystalo Plc Appoints Petra Gräsbeck as SVP, Communications and Public Affairs and Member of the Executive Team May 30
Terveystalo Plc Provides Earnings Guidance for the First Half and Full Year 2024 Apr 27
First quarter 2024 earnings released: EPS: €0.19 (vs €0.088 in 1Q 2023) Apr 26
Dividend of €0.15 announced Mar 28
Terveystalo Oyj Announces Election of Teija Sarajärvi as Member of Remuneration Committee Mar 27 Terveystalo Oyj Elects Teija Sarajärvi as Member of the Board
Upcoming dividend of €0.15 per share Mar 20
Tuomas Rissanen and Heidi Boman members of Sivupersoona management signed an agreement to acquire Sivupersoona Oy from Terveystalo Oyj (HLSE:TTALO) in a management buyout transaction. Mar 01
Full year 2023 earnings released: €0.33 loss per share (vs €0.19 profit in FY 2022) Feb 26
New major risk - Financial position Feb 17
Terveystalo plc Provides Earnings Guidance for 2024 Feb 15
Terveystalo plc Proposes Dividend for 2023 in Two Installments, Payable on April 8, 2024, and October 16, 2024, Respectively Feb 14
Terveystalo Oyj Announces Non Availability of Katri Viippola for Re-Election to the Board of Directors Nov 29
Terveystalo Oyj Announces Management Changes Nov 01
Third quarter 2023 earnings released: EPS: €0.03 (vs €0.15 loss in 3Q 2022) Oct 28 Terveystalo Oyj to Report Q1, 2024 Results on Apr 26, 2024
Upcoming dividend of €0.14 per share at 3.5% yield Sep 22 Terveystalo Oyj Provides Revenue Guidance for the Year 2023
New major risk - Financial position Jul 21
Second quarter 2023 earnings released: EPS: €0.059 (vs €0.088 in 2Q 2022) Jul 20
First quarter 2023 earnings released: EPS: €0.09 (vs €0.20 in 1Q 2022) Apr 29
High number of new directors Apr 02
Upcoming dividend of €0.14 per share at 4.1% yield Mar 17
Full year 2022 earnings released: EPS: €0.19 (vs €0.63 in FY 2021) Feb 12
Terveystalo Oyj Proposes Dividend for the Financial Year Ended 31 December 2022, Payable on 3 April 2023 and 9 October 2023 Feb 10
Terveystalo Oyj Announces Board Elections Dec 17
Terveystalo Oyj (HLSE:TTALO) acquired Somia Reality Oy. Nov 03
Terveystalo Oyj, Annual General Meeting, Mar 23, 2023 Oct 29 Terveystalo Oyj to Report Q1, 2023 Results on Apr 28, 2023
Third quarter 2022 earnings released: €0.15 loss per share (vs €0.11 profit in 3Q 2021) Oct 27 Terveystalo Oyj to Report Fiscal Year 2022 Results on Feb 10, 2023
Investor sentiment deteriorated over the past week Oct 17 Terveystalo Oyj Announces Changes in Executive Team
Upcoming dividend of €0.14 per share Sep 30
Terveystalo Plc Board Member Dag Andersson Passed Away Sep 29
Terveystalo Oyj Announces Composition of Shareholders Nomination Board Sep 14
Terveystalo Oyj (HLSE:TTALO) acquired Ludus Oy Tutkimus- ja Kuntoutuspalvelut. Sep 07
Terveystalo Oyj (HLSE:TTALO) acquired Ludus Oy Tutkimus- ja Kuntoutuspalvelut. Sep 06
Second quarter 2022 earnings released: EPS: €0.09 (vs €0.13 in 2Q 2021) Jul 19 Terveystalo Oyj Appoints Juuso Pajunen, B. 1981, M.Sc. (Econ.) as Member of the Executive Team
Terveystalo Oyj (HLSE:TTALO) acquired Kunnon Syke Oy. Jul 07 Terveystalo Plc Announces Nomination Board Changes
Terveystalo Oyj (HLSE:TTALO) acquired Into Terveys Oy. Jun 03
First quarter 2022 earnings released: EPS: €0.20 (vs €0.19 in 1Q 2021) Apr 30 Terveystalo Oyj Announces Board Changes
Terveystalo Oyj (HLSE:TTALO) acquired Suomen Fysiogeriatria Oy. Apr 06
Upcoming dividend of €0.14 per share Apr 01
Terveystalo Oyj (HLSE:TTALO) acquired Omt-klinikka Kokkola Oy. Apr 01
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 12
Terveystalo Plc Proposes Dividend for 2021 Feb 10
Terveystalo Oyj (HLSE:TTALO) acquired Suomen Hierojakoulut Oy. Dec 01
Third quarter 2021 earnings released: EPS €0.11 (vs €0.13 in 3Q 2020) Oct 29
Terveystalo Oyj (HLSE:TTALO) signed an agreement to acquire 80% stake in Medimar Scandinavia Ab. Sep 23
Terveystalo Oyj (HLSE:TTALO) acquired Sivupersoona Oy. Sep 02
Second quarter 2021 earnings released: EPS €0.13 (vs €0.012 loss in 2Q 2020) Aug 13
Terveystalo Oyj (HLSE:TTALO) signed an agreement to acquire Fysiopiste Mervi Nivukoski. Jun 05
First quarter 2021 earnings released: EPS €0.19 (vs €0.07 in 1Q 2020) May 02
Independent Director has left the company Mar 31
Upcoming Dividend of €0.13 Per Share Mar 19
New 90-day high: €11.47 Mar 15
Terveystalo Oyj (HLSE:TTALO) acquired Espoo Keskus Hammaslääkärit from Kirsi Jakobsson and Camilla Schröder. Feb 26
Terveystalo Oyj (HLSE:TTALO) signed an acquisition agreement to acquire the operations of Attentio Oy. Feb 18
Terveystalo Oyj Announces Retirement of Lasse Heinonen from Board of Directors Dec 11 Terveystalo Announces Management Changes, Effective 1 January 2021
New 90-day low: €9.60 Nov 27
Third quarter 2020 earnings released: EPS €0.13 Nov 02 Shareholder Returns 0RV1 GB Healthcare GB Market 7D -0.2% -2.1% -2.6% 1Y 31.2% -26.1% 2.4%
See full shareholder returns
Return vs Market: 0RV1 exceeded the UK Market which returned 2.7% over the past year.
Price Volatility Is 0RV1's price volatile compared to industry and market? 0RV1 volatility 0RV1 Average Weekly Movement 3.6% Healthcare Industry Average Movement 5.0% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.7% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0RV1 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0RV1's weekly volatility (4%) has been stable over the past year.
About the Company Terveystalo Oyj provides occupational healthcare services in Finland and internationally. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, surgery, outpatient surgery, dental, and other adjacent services; outsourcing and staffing services; child welfare services; and oral health, social, therapy and rehabilitation, social, ER, wellbeing, and primary health and special medical care services.
Show more Terveystalo Oyj Fundamentals Summary How do Terveystalo Oyj's earnings and revenue compare to its market cap? 0RV1 fundamental statistics Market cap €1.31b Earnings (TTM ) -€11.40m Revenue (TTM ) €1.33b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0RV1 income statement (TTM ) Revenue €1.33b Cost of Revenue €980.20m Gross Profit €348.30m Other Expenses €359.70m Earnings -€11.40m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
Earnings per share (EPS) -0.09 Gross Margin 26.22% Net Profit Margin -0.86% Debt/Equity Ratio 76.2%
How did 0RV1 perform over the long term?
See historical performance and comparison Dividends
2.9% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 06:23 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Terveystalo Oyj is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Iiris Theman Carnegie Investment Bank AB Panu Laitinmäki Danske Bank Sami Sarkamies Danske Bank
Show 6 more analysts 
